Clinical significance of antiphospholipid antibodies in fulminant hepatic failure.

@article{Tada1995ClinicalSO,
  title={Clinical significance of antiphospholipid antibodies in fulminant hepatic failure.},
  author={Koji Tada and Kouichi Akamatsu and Toshikazu Konno and Teruyo Ohuchi and Kazuaki Ohkubo and Ko Hayama and Satoshi Yamamoto and Tokio Wakabayashi and Yasuyuki Ohta},
  journal={Hepato-gastroenterology},
  year={1995},
  volume={42 1},
  pages={27-30}
}
We examined the incidence of antiphospholipid antibodies (APA) in patients with fulminant hepatic failure (FHF) and various liver diseases using the enzyme-linked immunosorbent assay (ELISA), and assessed possible correlations with the pathophysiology of these diseases. The APA assay employed cardiolipin (CL), phosphatidylserine (PS), and… CONTINUE READING